FDA advisory panel recommends the Pfizer vaccine to be authorized for children 5 to 11
A panel of independent vaccine experts recommended that the U.S. Food and Drug Administration (FDA), expand the authorization of the Pfizer BioNTech COVID-19 vaccine for children aged 5 to 11.…
